Max Healthcare Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve unaudited standalone ....
MAXHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Max Healthcare has informed the stock exchanges that its Board of Directors will meet on Friday, November 14, 2025, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (i.e., Q2 FY26 and H1 FY26). The company has also reaffirmed that the trading window for designated persons and their immediate relatives remains closed until 48 hours after the results are declared. This is a standard regulatory disclosure under SEBI's Listing Regulations, with no financial figures or business updates shared at this stage.
This is a procedural filing with no direct impact on share price or shareholders. Investors should watch for the actual results on November 14, which could materially move the stock depending on revenue growth, margins, and guidance.